Last update 14 Jul 2025

Linustedastat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
FOR-6219, OG-6219
Target
Action
inhibitors
Mechanism
17β-HSD1 inhibitors(Estradiol 17-beta-dehydrogenase 1 inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H29F2N3O2
InChIKeyRMMVCLGAUPAFAI-MLXDORPZSA-N
CAS Registry2254299-48-2

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pelvic PainPhase 2
United States
25 Oct 2022
Pelvic PainPhase 2
Belgium
25 Oct 2022
Pelvic PainPhase 2
Bulgaria
25 Oct 2022
Pelvic PainPhase 2
Czechia
25 Oct 2022
Pelvic PainPhase 2
France
25 Oct 2022
Pelvic PainPhase 2
Germany
25 Oct 2022
Pelvic PainPhase 2
Hungary
25 Oct 2022
Pelvic PainPhase 2
Italy
25 Oct 2022
Pelvic PainPhase 2
Latvia
25 Oct 2022
Pelvic PainPhase 2
Poland
25 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
jknuvaptsz(ameoiivgql) = OG-6219 did not demonstrate improvement in moderate-to-severe endometriosis-related overall pelvic pain compared to placebo. tjounnxmba (rwlcbjmkut )
Not Met
Negative
02 Jul 2025
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free